- Home
- AMRX vs FRPT Comparison
AMRX vs FRPT Comparison
Compare AMRX & FRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMRX
- FRPT
- Stock Information
- Founded
- AMRX 2002
- FRPT 2004
- Country
- AMRX United States
- FRPT United States
- Employees
- AMRX N/A
- FRPT N/A
- Industry
- AMRX Biotechnology: Pharmaceutical Preparations
- FRPT Packaged Foods
- Sector
- AMRX Health Care
- FRPT Consumer Staples
- Exchange
- AMRX Nasdaq
- FRPT Nasdaq
- Market Cap
- AMRX 3.3B
- FRPT 3.1B
- IPO Year
- AMRX N/A
- FRPT 2014
- Fundamental
- Price
- AMRX $10.21
- FRPT $52.15
- Analyst Decision
- AMRX Buy
- FRPT Buy
- Analyst Count
- AMRX 3
- FRPT 17
- Target Price
- AMRX $12.00
- FRPT $105.56
- AVG Volume (30 Days)
- AMRX 1.4M
- FRPT 1.4M
- Earning Date
- AMRX 10-30-2025
- FRPT 11-03-2025
- Dividend Yield
- AMRX N/A
- FRPT N/A
- EPS Growth
- AMRX N/A
- FRPT 28.97
- EPS
- AMRX 0.01
- FRPT 0.66
- Revenue
- AMRX $2,852,914,000.00
- FRPT $1,044,013,000.00
- Revenue This Year
- AMRX $9.70
- FRPT $15.98
- Revenue Next Year
- AMRX $6.53
- FRPT $12.11
- P/E Ratio
- AMRX $970.62
- FRPT $79.73
- Revenue Growth
- AMRX 9.81
- FRPT 19.30
- 52 Week Low
- AMRX $6.69
- FRPT $46.76
- 52 Week High
- AMRX $10.68
- FRPT $164.07
- Technical
- Relative Strength Index (RSI)
- AMRX 52.54
- FRPT 46.40
- Support Level
- AMRX $10.13
- FRPT $52.04
- Resistance Level
- AMRX $10.62
- FRPT $55.97
- Average True Range (ATR)
- AMRX 0.28
- FRPT 2.13
- MACD
- AMRX -0.01
- FRPT 0.26
- Stochastic Oscillator
- AMRX 57.02
- FRPT 43.06
About AMRX Amneal Pharmaceuticals Inc.
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.
About FRPT Freshpet Inc.
Freshpet produces and sells premium fresh pet food through its company-owned refrigerators placed in grocery, mass and club, pet specialty, and natural stores. Freshpet primarily targets dogs (96% of 2024 sales), with cats and treats comprising the rest of its sales. Geographically, the company's home US market, where all its food is produced, accounts for about 98% of sales, with exports to Canada, the United Kingdom, and other European countries accounting for the remaining balance.